Newsletter

Last Week in Healthcare Reform: May 23rd, 2022

A new study reinforces the link between hospital prices and market share; unnecessary care is found to have persisted during the pandemic; stakeholders continue to urge for full implementation of consumer surprise medical billing protections; and, Medicare spending on prescription drugs outpaces R&D costs.

Last Week in Healthcare Reform: May 16th, 2022

Hospitals look to historic rate increases to cover their costs; millions threatened with loss of coverage after the public health emergency ends; a reminder that drugmakers are ultimately the ones responsible for controlling insulin costs; and, stakeholders continue to defend the Medicare Advantage program.

Last Week in Healthcare Reform: May 9th, 2022

A new report shines a light on hospital drug errors; elsewhere, trends point to broad geographic variation in hospital pricing; stakeholders rally to the defense of the critical Medicare Advantage program; and, a look at how Big Pharma exploits the patent system to its own benefit.

Last Week in Healthcare Reform: May 2nd, 2022

Access for Maine consumers threatened by hospital system; the Administration appeals a surprise medical billing court ruling; private equity continues to exert pressure on our healthcare delivery model; and, a look at how access to Medicaid impacts health equity.

Last Week in Healthcare Reform: April 25th, 2022

An important milestone is reached for new consumer surprise medical billing protections; proposed changes to Medicare Advantage are finalized; a new study takes a look at nonprofit hospitals’ charity care; and, rising drug prices continue to leave vulnerable populations exposed.

Last Week in Healthcare Reform: April 18th, 2022

An important milestone is reached for new consumer surprise medical billing protections; proposed changes to Medicare Advantage are finalized; a new study takes a look at nonprofit hospitals’ charity care; and, rising drug prices continue to leave vulnerable populations exposed.

Last Week in Healthcare Reform: April 11th, 2022

Premiums in Medicare Part D plans that cap insulin costs are higher than those that don’t; audio-only telehealth continues to play a critical role in connecting patients to care; unexpected medical bills rank amongst consumers’ biggest financial worries; and, new projections provide insights into where our healthcare spending might be headed.

Last Week in Healthcare Reform: April 4th, 2022

Stakeholders continue to urge for full implementation of consumer surprise medical billing protections; a new report seeks to clarify the relationship between PBMs and drug prices; studies link rising costs and low-value to care delivered by hospital-employed physicians; and, a focus on value-based care improves outcomes and reduces costs.

Last Week in Healthcare Reform: March 28th, 2022

Scapegoating PBMs diverts focus away from who’s really to blame for high drug prices; meanwhile, research continues to poke holes in Big Pharma’s innovation rhetoric; a new campaign is launched highlighting the value of employer-provided health coverage; and, patients want hospitals to disclose emergency room fees.